上案例=品牌药物下部病例=通用药物处方药名称更改margenza j9353移至非脱颖而出的Enhertu J9358转移到首选的Kadcyla J9354迁移到首选Perjeta J9306迁移到首选Phesgo J9316转移到首选Monoferric J1437的Predred Perjeta J9306转移到首选phesgo j1437迁移到非脱颖而出的bivigam J1556的非脱颖而出的Asceniv J1556转移到非脱颖而出的γ1556迁移到非脱颖而出的Gamunex-C J1556转移到非脱颖而出的panzyga panzyga J1576转向非偏爱的j1569 ipperred j1569 exprield j1569 j1557移至首选Octagam J1568移至首选私人J1459转移到首选
avasttin(仅OCTTIN诊断)bevacizumab(仅刻薄诊断)C9257 J9035 AVSOLA英夫斯洛拉英夫利昔单抗-AXXQ Q5121 avzivi bevacizumab-tnjn A9590 Bavencio avelumab J9023 Beleodaq Belinostat J9032 Belrapzo Bendamistine J9036 Bendeka Benlysta(iv)Belimumab J0490 Beqvez findacogene findacogene elaparvovece elaparvovec j1414 besponsa besponsa besponsa besponsa besponsa besponsa besponsa besponsa Inotuzumab J9229 Bivigam Immune Globulin(人)IV J1556 Blincyto Blinatumomab J9039 Botox Onbotulanum毒素A J0585 Beryanzi lisocababtagene lisocabtagene Maraleucel Maraleucel Q2054 Brainneura cerliponase alfa j0567 j0567 bkem j0567 bkem Eculizumab-AEEB Q5139 Carimune纳米滤器IV J1566 Carticogos软骨细胞J7330 Ciltacabtagene Autoleucel Q2 J3392 Cerezyme Imiglucerase J1786 CINQAIR RESLIZUMAB J2786 COLUMVII GLOFITAMAB-GXBM J9286 COSELA TRILACICLIB J1448 COSENTYX IV SECUKINUMAB J3247 CRYSVITA BURODUMUMAB J055 cUSTAMAB J0584 CUTAUNEN4 CUTAUNEN4 (Human) subcutaneous j1551 cumtru immune globulin (human) subcutaneous j1555 cyramza ramucirub j9308 daanyelza naxitamab-gqgk j9348 darzalex daratuummab j9145 darzalex fasprondase-fihjj J9144 DAXXIFY DAXIBOTULLINUMTOXINA-LANM J0589 DURALANE透明质酸J7318,
